Ethics and malpractice statements of the Asia Oceania Journal of Nuclear Medicine & Biology are based on COPE’s Best Practice Guidelines for Journal Editors and pertain to all parties involved in the publishing: the editor, the peer reviewer, and the author. If there is an allegation of plagiarism, scientific misconduct, or fraud, AOJNMB shall follow the recommendations of the Uniform Requirements and reserves the right to present the allegations to the author’s institution or any other agency. Submission of any manuscript to AOJNMB signifies that it is original and it has not been published anywhere before (except as a congress abstract of no more than 350 words) nor it is under consideration by another journal.
Transparency involves the author understanding and accepting certain publication policies:
i) Declaration of interests—it is important to declare the funding that made the research possible.
ii) Registering clinical trials—clinical trials should be registered in publicly accessible registries.
iii) Respecting confidentiality—protecting patients from being recognized if used in research and in publication.
iv) Protecting research subjects, patients, and experimental animals.
Each individual listed as an author on the title page of a submitted manuscript should have met the criteria for authorship as established by the International Committee of Medical Journal Editors (ICMJE). Each author must contribute substantially to research design, or the acquisition, analysis, or interpretation of data as well as contribute to the drafting of the paper or revising it critically. We think that more than 8 authors is unusal in each study, and AOJNMB strongly discourage inclusion of ghost authors. In exceptional cases of large international or national studies which number of authors might exceed the limit, the details of contribution of each author should be written for clarification.
By virtue of the submitted manuscript, the corresponding author acknowledges that all the co-authors have seen and approved the final version of the manuscript. The corresponding author should provide all co-authors with information regarding the manuscript, and obtain their approval as well as the approval of their institute before submitting any revisions. The authors are responsible for the whole scientific content as well as the accuracy of the bibliographic information. Also, the authors must confirm that the article contains no libelous or other unlawful statements and does not contain any materials that violate any personal or proprietary rights of any other person or entity. The authors also confirm that have obtained written permission from copyright owners for any excerpts from copyrighted works that are included and have credited the sources in their article. Also If authors are using any personal details or images of patients or research subjects, they have obtained written permission or consent from the patient.
Statement of Human and Animal Rights for AOJNMB;
All manuscripts reporting the results of experimental investigations involving human subjects should include a statement, confirming that informed written consent was obtained from each subject or the subject’s guardian. The study must also be approved by the local ethics committee and the study must comply with the 1964 Declaration of Helsinki and its subsequent revisions.
For animal studies, it must be in compliance with the regulation(s) of a local institution and with generally accepted guidelines governing such work.
All prospective clinical trials must be registered. Registration of prospective clinical trials must be done in one of the publicly accessible registries and the registration number must be provided at the end of the abstract.
Statement of informed consent for the Asia Oceania Journal of Nuclear Medicine & biology;
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.
Conflict of interest:
At the time of submission of the manuscript, all authors must disclose any type of conflict of interest including but not limited to financial interests that may influence the submitted manuscript. Any company consultancy, product or stock ownership related to the manuscript must be disclosed. Affiliations of authors should include corporate appointments relating to or in connection with the products or companies mentioned in the article. Authors should declare sources of funding for the work undertaken. If there is no conflict of interest for all of the authors, the phrase ‘No potential conflicts of interest were disclosed’ should be written in the acknowledgment.
Regulations for Publication Ethics and Malpractice Statement in the Asia Oceania Journal of Nuclear Medicine and Biology;
Section A: Publication and authorship
Section B: Authors' responsibilities
Section C: Peer review/responsibility for the reviewers
Section D: Editorial responsibilities
Section E: Publishing Ethics Issues